Home

Report

The Use of Medicines in the U.S. 2023

The Use of Medicines in the U.S. 2023

IQVIA
Pages 74 Pages

This annual report analyzes U.S. medicine usage and spending trends through 2023. It highlights growth driven by specialty medicines, oncology, and chronic disease therapies, alongside continued cost pressures for patients and payers. The report examines the role of generics and biosimilars in moderating spending and discusses policy impacts, including early effects of the Inflation Reduction Act. Forward-looking insights address affordability, access, and innovation balance.

Join for free to read

You Might Also Like


The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S. 2024
Report The Use of Medicines in the U.S. 2024
IQVIA

Understanding the Use of Medicines
Report Understanding the Use of Medicines
IQVIA

More from IQVIA


The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S. 2024
Report The Use of Medicines in the U.S. 2024
IQVIA

Understanding the Use of Medicines
Report Understanding the Use of Medicines
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info